Following Legislative Changes, it is Essential the Pharmacist Avoids Confusion



  • A report by Antares Consulting highlights the importance of this profession in ensuring adherence.
  • The scenario was created following the approval of RDL 16/2012 which means the pharmacist plays a key role.


Recent legislative developments have occurred in Spain for "adjustments" approved by the government that have particulary affected the sector, leading to a series of changes that have affected the course of action for Spanish pharmacists. For example, the adoption of the Royal Decree Law 16/2012 and the changes in the allocation of 'lowest price', have made the performance of the pharmacist to become "especially important" in relation to avoiding possible confusion of the patient to contintue treatment.


This is well evidenced by a report of Pharmacy Outlook by Antares Consulting, "Attitude of the pharmacist before the prescription by active ingredient," which analyzes the role of Spanish pharmacists with respect to the new form of action. In it, it states that the context created by the RDL 16/2012 and the changes in the allocation of 'lowest price' will "cause constant forced substitutions and the need for new instructions to patients that are already familiar with their mediciations."


The PPA required


Similarly, and with respect to the obligation of prescribing by active ingredient in all of Spain, the report notes that in the current situation generated b this circumstance "pharmaceutical professionals are concerned by the possible confusion that their patients may have about their medication." Changes that could cause confusion in the organization and management of medication by the patient are, "the doubts generated in recognition of their medication in the packages and the bio-appearance."


Therefore, the study done by Antares Consulting highlights the work of the pharmacist because, "when we talk about drug substitution it is important that the patient is aware of the change and that this has not caused confusion." In this regard, the report states that this concept is different from the possible problems of adherence to the treatment.


In this sense, Antares insists that "therapeutic adherence is a 'multifactorial' issue where the patients own perception about the sickness and the necessity to be treated is the fundamental basis for regular intake of drugs. Do not confuse this important concept to possible confusions with the box of medication.



On one hand, note that the confidence of the patients in the pharmacists work to prevent confusion is palpable. Thus, in 2010, the Pharmacy Outlook report by Antares Consulting conducted with 1,250 patients in all of Spain revealed that 85% of respondents " showed a lot of confidence in the choice of pharmacist in the dispensing of a bio-equivalent drug."


As demonstrated in another survery of the Pharmacy Outlook by Antares, conducted in 2012 with 450 Community Pharmacy holders, a citizen has confidence that these health professionals have knowledge since a large majority of them are aware of the possible problems with confusion in patients in the case of constant changing medicines.


Indeed, 82% of the pharmacists surveyed said that after selecting the drug "they maintained the same product in subsequent times so that the patient didn´t have problems with confusion." In those cases where this is not possible, the report prepared by Antares Consulting shows that "the pharmacist conducts information for the patient about the characteristics of the new format and appearance, highlighting the concept of bio-equivalence." 

Source:The Global
Access to the original news

Copyright © 2019 Antares Consulting S.L. All rights reserved   |   Legal information and Privacy policy